Kidney Care: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Kidney Care
Largest movements
- Cash +€52,883
up €52,883 (+881.4%), from €6,000 to €58,883
mainly Net result for the year (+€126,193) and Depreciation (+€1,344)
- Receivables within one year +€39,480
new in 2025: €39,480
of which Other amounts receivable: +€30,012
- Deferred charges and accrued income +€9,648
up €9,648 (+18.1%), from €53,375 to €63,023
- Tangible fixed assets +€2,382
new in 2025: €2,382
- Reserves +€126,193
up €126,193 (+402.1%), from €31,383 to €157,576
- Trade debts -€14,452
down €14,452 (-95.5%), from €15,140 to €689
- Tax, wage and social debts -€3,573
down €3,573 (-45.1%), from €7,927 to €4,353
- Other debts -€3,573
no longer reported in 2025 (was €3,573)
- Gross operating margin +€125,461
up €125,461 (+318.4%), from €39,400 to €164,861
- Taxes +€28,427
up €28,427 (+358.6%), from €7,927 to €36,353
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €65,459 | €168,618 | +€103,159 | +157.6% |
| Formation expenses | 20 | €6,084 | €4,850 | -€1,235 | -20.3% |
| Fixed assets | 21/28 | - | €2,382 | +€2,382 | |
| Tangible fixed assets | 22/27 | - | €2,382 | +€2,382 | |
| Furniture and vehicles | 24 | - | €2,382 | +€2,382 | |
| Current assets | 29/58 | €59,375 | €161,387 | +€102,012 | +171.8% |
| Amounts receivable within one year | 40/41 | - | €39,480 | +€39,480 | |
| Trade receivables | 40 | - | €9,468 | +€9,468 | |
| Other amounts receivable | 41 | - | €30,012 | +€30,012 | |
| Cash at bank and in hand | 54/58 | €6,000 | €58,883 | +€52,883 | +881.4% |
| Deferred charges and accrued income | 490/1 | €53,375 | €63,023 | +€9,648 | +18.1% |
| Total equity and liabilities | 10/49 | €65,459 | €168,618 | +€103,159 | +157.6% |
| Equity | 10/15 | €37,383 | €163,576 | +€126,193 | +337.6% |
| Contributions | 10/11 | €6,000 | €6,000 | = | 0.0% |
| Reserves | 13 | €31,383 | €157,576 | +€126,193 | +402.1% |
| Distributable reserves | 133 | €31,383 | €157,576 | +€126,193 | +402.1% |
| Amounts payable | 17/49 | €28,076 | €5,042 | -€23,034 | -82.0% |
| Amounts payable within one year | 42/48 | €26,640 | €5,042 | -€21,598 | -81.1% |
| Trade debts | 44 | €15,140 | €689 | -€14,452 | -95.5% |
| Suppliers | 440/4 | €15,140 | €689 | -€14,452 | -95.5% |
| Taxes, remuneration and social security | 45 | €7,927 | €4,353 | -€3,573 | -45.1% |
| Taxes | 450/3 | €7,927 | €4,353 | -€3,573 | -45.1% |
| Other amounts payable | 47/48 | €3,573 | - | -€3,573 | |
| Accrued charges and deferred income | 492/3 | €1,436 | - | -€1,436 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €90 | €1,344 | +€1,254 | +1390.3% |
| Gross operating margin | 9900 | €39,400 | €164,861 | +€125,461 | +318.4% |
| Operating profit (loss) | 9901 | €39,310 | €163,517 | +€124,207 | +316.0% |
| Financial charges | 65/66B | - | €970 | +€970 | |
| Recurring financial charges | 65 | - | €970 | +€970 | |
| Profit (loss) for the period before taxes | 9903 | €39,310 | €162,547 | +€123,237 | +313.5% |
| Income taxes | 67/77 | €7,927 | €36,353 | +€28,427 | +358.6% |
| Profit (loss) for the period | 9904 | €31,383 | €126,193 | +€94,810 | +302.1% |
| Profit (loss) for the period to be appropriated | 9905 | €31,383 | €126,193 | +€94,810 | +302.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.